MedTrace Logo

Intravenous Acetaminophen Use With Bariatric Surgery on Morbidly Obese Patients

NCT01527942 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2015-12-17

Study results available
· View outcomes & findings →

Summary

Bariatric patients usually require the use of either intravenous or oral opioid medications. The use of opioids, however, is often associated with side-effects such as nausea, sedation pruritus, urinary retention and respiratory depression with often delay patient discharge. This study makes use of intravenous acetaminophen , a non-opioid analgesic preoperatively to determine if this will decrease the use of opioids post-operatively for pain management in morbidly obese patients undergoing laparoscopic bariatric surgery.

Conditions

Interventions

DRUG

Acetaminophen

Intravenous Acetaminophen 1,000 mg IV

DRUG

Placebo

Placebo - IV administration 0.9% 100 ml Sodium Chloride (NaCl)

Sponsors & Collaborators

  • Trinity Health Of New England

    lead OTHER

Principal Investigators

  • Ioannis Raftopoulos, MD · Saint Francis

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01527942 on ClinicalTrials.gov